Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingkang Huang

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Plos One|June 2, 2023
Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indicationsGilad Vainer, Lingkang Huang, Kenneth Emancipator, et al.
Cancer Informatics|August 23, 2013
Improved Sparse Multi-Class SVM and Its Application for Gene Selection in Cancer ClassificationLingkang Huang, Hao Helen Zhang, Zhao-Bang Zeng, et al.
Statistics in Medicine|July 8, 2022
CAPITAL: Optimal subgroup identification via constrained policy tree searchHengrui Cai, Wenbin Lu, Rachel Marceau West, et al.
Cancer Cytopathology|February 8, 2018
Use of the 22C3 anti-programmed death-ligand 1 antibody to determine programmed death-ligand 1 expression in cytology samples obtained from non-small cell lung cancer patientsMarius Ilie, Jonathan Juco, Lingkang Huang, et al.
BMC Genomics|June 19, 2008
Genes related to apoptosis predict necrosis of the liver as a phenotype observed in rats exposed to a compendium of hepatotoxicantsLingkang Huang, Alexandra N Heinloth, Zhao-Bang Zeng, et al.
Respiratory Medicine|April 26, 2016
Genetic effects on treatment response of umeclidinium/vilanterol in chronic obstructive pulmonary diseaseLynn Condreay, Lingkang Huang, Elizabeth Harris, et al.
Plos One|October 14, 2017
Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platformsMarius Ilie, Shirin Khambata-Ford, Christiane Copie-Bergman, et al.
Plos One|August 11, 2017
Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platformsMarius Ilie, Shirin Khambata-Ford, Christiane Copie-Bergman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 28, 2013
Genetic analysis of asthma exacerbationsWayne H Anderson, Beena T Koshy, Lingkang Huang, et al.
Immunity|January 5, 2022
Germline HLA landscape does not predict efficacy of pembrolizumab monotherapy across solid tumor typesAparna Chhibber, Lingkang Huang, Hong Zhang, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Plos One|June 2, 2023
Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indicationsGilad Vainer, Lingkang Huang, Kenneth Emancipator, et al.
Cancer Informatics|August 23, 2013
Improved Sparse Multi-Class SVM and Its Application for Gene Selection in Cancer ClassificationLingkang Huang, Hao Helen Zhang, Zhao-Bang Zeng, et al.
Statistics in Medicine|July 8, 2022
CAPITAL: Optimal subgroup identification via constrained policy tree searchHengrui Cai, Wenbin Lu, Rachel Marceau West, et al.
Cancer Cytopathology|February 8, 2018
Use of the 22C3 anti-programmed death-ligand 1 antibody to determine programmed death-ligand 1 expression in cytology samples obtained from non-small cell lung cancer patientsMarius Ilie, Jonathan Juco, Lingkang Huang, et al.
BMC Genomics|June 19, 2008
Genes related to apoptosis predict necrosis of the liver as a phenotype observed in rats exposed to a compendium of hepatotoxicantsLingkang Huang, Alexandra N Heinloth, Zhao-Bang Zeng, et al.
Respiratory Medicine|April 26, 2016
Genetic effects on treatment response of umeclidinium/vilanterol in chronic obstructive pulmonary diseaseLynn Condreay, Lingkang Huang, Elizabeth Harris, et al.
Plos One|October 14, 2017
Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platformsMarius Ilie, Shirin Khambata-Ford, Christiane Copie-Bergman, et al.
Plos One|August 11, 2017
Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platformsMarius Ilie, Shirin Khambata-Ford, Christiane Copie-Bergman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 28, 2013
Genetic analysis of asthma exacerbationsWayne H Anderson, Beena T Koshy, Lingkang Huang, et al.
Immunity|January 5, 2022
Germline HLA landscape does not predict efficacy of pembrolizumab monotherapy across solid tumor typesAparna Chhibber, Lingkang Huang, Hong Zhang, et al.
Pageof 3